Deutsche Bank Aktiengesellschaft »

Longboard Pharmaceuticals In shares owned by Deutsche Bank Aktiengesellschaft

Quarter-by-quarter ownership of Longboard Pharmaceuticals In (LBPH) shares owned by Deutsche Bank Aktiengesellschaft from 13F filings

Historical chart of Deutsche Bank Aktiengesellschaft investment in Longboard Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Longboard Pharmaceuticals In held by Deutsche Bank Aktiengesellschaft consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Longboard Pharmaceuticals In by Deutsche Bank Aktiengesellschaft

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.3M 68k 33.33
2024-06-30 $372k 14k 27.03
2024-03-31 $242k 11k 21.60

More positions owned by Deutsche Bank Aktiengesellschaft

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
UnitedHealth (UNH)
JPMorgan Chase & Co. (JPM)
Broadcom (AVGO)
Visa Com Cl A (V)
Johnson & Johnson (JNJ)
Tesla Motors (TSLA)
Merck & Co (MRK)

View all positions for Deutsche Bank Aktiengesellschaft

Top funds holding Longboard Pharmaceuticals In

Farallon Capital Management
T. Rowe Price Associates
BlackRock
Cormorant Asset Management
BlackRock
Viking Global Investors
Vanguard Group
Woodline Partners
Pictet Asset Management Holding SA
Jennison Associates
Siren
State Street Corporation
Geode Capital Management
Driehaus Capital Management
Parkman Healthcare Partners

View all funds holding Longboard Pharmaceuticals In